高灵敏度肌钙蛋白T风险分层策略对90天内心脏性死亡或心肌梗死的影响

Q3 Medicine
R Gentry Wilkerson, Nicklaus P Ashburn, Anna C Snavely, Brandon R Allen, Robert H Christenson, Michael Weaver, Xiaoxi Zhang, Troy E Madsen, Bryn E Mumma, Michael W Supples, Simon A Mahler
{"title":"高灵敏度肌钙蛋白T风险分层策略对90天内心脏性死亡或心肌梗死的影响","authors":"R Gentry Wilkerson, Nicklaus P Ashburn, Anna C Snavely, Brandon R Allen, Robert H Christenson, Michael Weaver, Xiaoxi Zhang, Troy E Madsen, Bryn E Mumma, Michael W Supples, Simon A Mahler","doi":"10.1097/HPC.0000000000000397","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Thirty-day performance of the high-sensitivity troponin T (hs-cTnT) European Society of Cardiology 0/1-hour (ESC 0/1-h) and \"one-and-done\" (hs-cTnT<limit of quantification [LoQ]) strategies are established. However, 90-day performance is unclear. Our objective was to evaluate the 90-day performance of these hs-cTnT strategies in a U.S. cohort.</p><p><strong>Methods: </strong>A pre-planned secondary analysis of a prospective multisite U.S. cohort was conducted. Adults with chest pain were enrolled from eight emergency departments (1/2017-9/2018). hs-cTnT measures (0- and 1-h) were used to classify patients by the ESC 0/1-h algorithm into rule-out, observation, and rule-in zones. Patients with 0-h measures <LoQ were considered ruled-out by the one-and-done strategy. The primary outcome was adjudicated 90-day cardiac death or MI. Negative predictive value (NPV) for the primary endpoint and efficacy (proportion ruled-out) were calculated for each strategy alone and in combination with the HEART score.</p><p><strong>Results: </strong>Among 1462 patients with a mean age of 57.6±12.9 years, 46.4% (678/1462) were female and 14.0% (205/1462) had cardiac death or MI at 90 days. One-and-done strategy efficacy was 32.8% (479/1462) and NPV was 99.0% (95%CI, 97.6-99.7). Adding the HEART score decreased efficacy to 20.1% (293/1462) and increased NPV to 99.7% (95%CI, 98.1-100). ESC 0/1-h efficacy was 57.8% (826/1430) and NPV was 98.3% (95%CI, 97.2-99.1). Combined with a HEART score NPV increased to 99.3% (95%CI, 98.0-99.9) but efficacy decreased to 30.8% (95%CI, 28.3-33.2).</p><p><strong>Conclusion: </strong>The one-and-done strategy and ESC 0/1-hour algorithm had modest rates of missed 90-day cardiac death or MI. Adding a HEART score improved safety but decreased efficacy.</p>","PeriodicalId":35914,"journal":{"name":"Critical Pathways in Cardiology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Performance of High-Sensitivity Troponin T Risk Stratification Strategies for 90-day Cardiac Death or Myocardial Infarction.\",\"authors\":\"R Gentry Wilkerson, Nicklaus P Ashburn, Anna C Snavely, Brandon R Allen, Robert H Christenson, Michael Weaver, Xiaoxi Zhang, Troy E Madsen, Bryn E Mumma, Michael W Supples, Simon A Mahler\",\"doi\":\"10.1097/HPC.0000000000000397\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Thirty-day performance of the high-sensitivity troponin T (hs-cTnT) European Society of Cardiology 0/1-hour (ESC 0/1-h) and \\\"one-and-done\\\" (hs-cTnT<limit of quantification [LoQ]) strategies are established. However, 90-day performance is unclear. Our objective was to evaluate the 90-day performance of these hs-cTnT strategies in a U.S. cohort.</p><p><strong>Methods: </strong>A pre-planned secondary analysis of a prospective multisite U.S. cohort was conducted. Adults with chest pain were enrolled from eight emergency departments (1/2017-9/2018). hs-cTnT measures (0- and 1-h) were used to classify patients by the ESC 0/1-h algorithm into rule-out, observation, and rule-in zones. Patients with 0-h measures <LoQ were considered ruled-out by the one-and-done strategy. The primary outcome was adjudicated 90-day cardiac death or MI. Negative predictive value (NPV) for the primary endpoint and efficacy (proportion ruled-out) were calculated for each strategy alone and in combination with the HEART score.</p><p><strong>Results: </strong>Among 1462 patients with a mean age of 57.6±12.9 years, 46.4% (678/1462) were female and 14.0% (205/1462) had cardiac death or MI at 90 days. One-and-done strategy efficacy was 32.8% (479/1462) and NPV was 99.0% (95%CI, 97.6-99.7). Adding the HEART score decreased efficacy to 20.1% (293/1462) and increased NPV to 99.7% (95%CI, 98.1-100). ESC 0/1-h efficacy was 57.8% (826/1430) and NPV was 98.3% (95%CI, 97.2-99.1). Combined with a HEART score NPV increased to 99.3% (95%CI, 98.0-99.9) but efficacy decreased to 30.8% (95%CI, 28.3-33.2).</p><p><strong>Conclusion: </strong>The one-and-done strategy and ESC 0/1-hour algorithm had modest rates of missed 90-day cardiac death or MI. Adding a HEART score improved safety but decreased efficacy.</p>\",\"PeriodicalId\":35914,\"journal\":{\"name\":\"Critical Pathways in Cardiology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-07-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Critical Pathways in Cardiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/HPC.0000000000000397\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Critical Pathways in Cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/HPC.0000000000000397","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

背景:高敏感性肌钙蛋白T (hs-cTnT) 30天欧洲心脏病学会0/1小时(ESC 0/1-h)和“一次完成”(hs-cTnT)的表现方法:对一项前瞻性多地点美国队列进行了预先计划的二次分析。从8个急诊科(2017年1月至2018年9月)招募了胸痛的成年人。hs-cTnT测量值(0-和1-h)通过ESC 0/1-h算法将患者分为排除区、观察区和规则入区。结果:1462例平均年龄为57.6±12.9岁的患者中,46.4%(678/1462)为女性,14.0%(205/1462)在90天发生心源性死亡或心肌梗死。一次性策略有效率为32.8% (479/1462),NPV为99.0% (95%CI, 97.6-99.7)。增加HEART评分使疗效降低至20.1% (293/1462),NPV增加至99.7% (95%CI, 98.1-100)。ESC 0/1-h有效率为57.8% (826/1430),NPV为98.3% (95%CI, 97.2 ~ 99.1)。结合HEART评分,NPV增加到99.3% (95%CI, 98.0-99.9),但疗效下降到30.8% (95%CI, 28.3-33.2)。结论:一次完成策略和ESC 0/1小时算法具有中等的90天心脏死亡或心肌梗死漏诊率。增加HEART评分提高了安全性,但降低了疗效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Performance of High-Sensitivity Troponin T Risk Stratification Strategies for 90-day Cardiac Death or Myocardial Infarction.

Background: Thirty-day performance of the high-sensitivity troponin T (hs-cTnT) European Society of Cardiology 0/1-hour (ESC 0/1-h) and "one-and-done" (hs-cTnT

Methods: A pre-planned secondary analysis of a prospective multisite U.S. cohort was conducted. Adults with chest pain were enrolled from eight emergency departments (1/2017-9/2018). hs-cTnT measures (0- and 1-h) were used to classify patients by the ESC 0/1-h algorithm into rule-out, observation, and rule-in zones. Patients with 0-h measures

Results: Among 1462 patients with a mean age of 57.6±12.9 years, 46.4% (678/1462) were female and 14.0% (205/1462) had cardiac death or MI at 90 days. One-and-done strategy efficacy was 32.8% (479/1462) and NPV was 99.0% (95%CI, 97.6-99.7). Adding the HEART score decreased efficacy to 20.1% (293/1462) and increased NPV to 99.7% (95%CI, 98.1-100). ESC 0/1-h efficacy was 57.8% (826/1430) and NPV was 98.3% (95%CI, 97.2-99.1). Combined with a HEART score NPV increased to 99.3% (95%CI, 98.0-99.9) but efficacy decreased to 30.8% (95%CI, 28.3-33.2).

Conclusion: The one-and-done strategy and ESC 0/1-hour algorithm had modest rates of missed 90-day cardiac death or MI. Adding a HEART score improved safety but decreased efficacy.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Critical Pathways in Cardiology
Critical Pathways in Cardiology Medicine-Medicine (all)
CiteScore
1.90
自引率
0.00%
发文量
52
期刊介绍: Critical Pathways in Cardiology provides a single source for the diagnostic and therapeutic protocols in use at hospitals worldwide for patients with cardiac disorders. The Journal presents critical pathways for specific diagnoses—complete with evidence-based rationales—and also publishes studies of these protocols" effectiveness.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信